ONCS - OncoSec Medical - Stock Forecast

Biotechnology & Medical Research - Industry

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

OncoSec Medical's activity chart (see below) currently has 2 price targets and 2 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 40% with an average time for these price targets to be met of 348.8 days.

Most recent stock forecast was given by JASON KOLBERT from DAWSON JAMES on 17-Mar-2022.

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 27-Jul-2020

$220

Buy Since 31-Jul-2019

$12

$12 (0.00%)

Buy Since 12-Dec-2018

$660

Show more analysts

What is ONCS (OncoSec Medical) average time for price targets to be met?

On average it took 348.8 days on average for the stock forecasts to be realized with a an average price target met ratio 40

Which analyst has the current highest performing score on ONCS (OncoSec Medical) with a proven track record?

JASON MCCARTHY

Which analyst has the current lower performing score on ONCS (OncoSec Medical) with a proven track record?

KAVERI POHLMAN

Which analyst has the most public recommendations on ONCS (OncoSec Medical)?

Jason Mccarthy works at MAXIM GROUP and has 1 price targets and 0 ratings on ONCS

Which analyst is the currently most bullish on ONCS (OncoSec Medical)?

Jason Mccarthy with highest potential upside - $12

Which analyst is the currently most reserved on ONCS (OncoSec Medical)?

Edward Tenthoff with lowest potential downside - -$0